Micropapillary thyroid cancer;
Lymph node;
Recurrence;
CENTRAL COMPARTMENT;
ASSOCIATION GUIDELINES;
STAGING SYSTEM;
METASTASIS;
SURVIVAL;
CANCER;
MANAGEMENT;
PROGNOSIS;
CARCINOMA;
MALIGNANCY;
D O I:
10.1308/rcsann.2022.0094
中图分类号:
R61 [外科手术学];
学科分类号:
摘要:
Introduction Lymph node (LN) metastases in papillary thyroid microcarcinomas (microPTCs) are common. The lymph node ratio (LNR) has been proposed as a risk factor for recurrence in papillary thyroid cancer. However, its relevance in microPTC is undetermined. Methods Patients who underwent resection of their microPTC with concomitant LN clearance between 2005 and 2018 were identified. The LNR was calculated as the ratio of positive LNs to the total number of LNs.Results Data on 50 patients (36 female [72%]; median age 47 years [range: 19-84]) who underwent LN clearance (28 central [56%] vs 22 central + lateral [44%]) were analysed. Positive LNs were found in over two-thirds of the patients (n = 34; 68%). After a median follow-up of 61 months, 14 patients (28%) had developed recurrence. Positive LNs were not found to impact recurrence-free survival; extranodal extension and an LNR >= 0.26 were found to significantly increase the risk of recurrence on unadjusted analyses (p < 0.05). Conclusions LN metastases are frequent among patients with microPTC. A higher LNR seems to be associated with recurrence. Additional studies are needed to further clarify these findings and to assess the possible role of LNR in treatment and surveillance.